Inclusionary Digital Health Webinar

Insights from Industry: Inclusionary Digital Health

The Black and Brown in Bioethics network aims to bring together different sectors and share good inclusive practice, focusing on approaches to remove barriers and allow everyone to engage meaningfully in our futures. This webinar, organised by Matimba, focused on digital health from an industry perspective with the aim to evaluate and discuss: (1) the past, present and future digital health landscape, (2) digital health inequalities, (3) digital health inclusion strategies and (4) why digital inequalities and inclusion matter in healthcare.

We were delighted to be joined by Evelyn (Eve) Kamau (Thermo Fisher Scientific), Niyoshi Shah (Quicksand Design Studio) and Srushhti Trivedi (Amaris Consulting). We are also grateful to Arianna Manzini (DeepMind), who chaired the session.

Watch the webinar recording here:


About the Speakers

Niyoshi Shah (she/her) – Consultant, Quicksand Design Studio.

Niyoshi is a qualitative researcher and writer who completed her Masters in Critical Writing from the Royal College of Art, London in 2018. Her thesis on the uptake of protective footwear for leprosy in India was shown at the International Leprosy Congress, Manila (2019), and shortlisted for the NTD Innovation Prize by the American Leprosy Mission (2019). Niyoshi has also worked on evidence-led IEC for suicide prevention and mental health in the past. This aligns with her longstanding interest in the question of linguistic equity, where she is constantly looking for ways to improve health and care access for those who don’t consider English their dominant language. Her concerns regarding culturally-sensitive communication were presented as a case study at the Global Forum on Bioethics in Research (2021). Niyoshi currently works with Quicksand Design Studio on their projects in the social sector with a special focus on health, and new technologies. Her writing has been featured by the Wellcome Collection, Fifty Two, and Sindroms to name a few publications.

Evelyn (Eve) Kamau (she/her) – Senior Director, DCT Strategy and Innovation, PPD part of Thermofisher Scientific

Eve is a Senior Director in the Digital and Decentralized Solutions unit of the clinical research group and the SME for home trial services. She has been a nurse for over 20 years, with both UK and international nursing experience. In addition to critical care, neurology, clinical trials, and community nursing experience, Eve has a special focus in decentralized clinical trials where she has helped support over 100 clinical trials, in the home environment over the past seven years.

Srushhti Trivedi (she/her) – Consultant | Educator | Ethicist, Amaris Consulting

Srushhti is currently working as a full-time consultant in the evidence review team at Amaris Consulting. She works in their Life science consulting where they support pharmaceutical clients in Drug reimbursement submissions. She is also an Ethics expert at Ethical Intelligence and advise on  developing AI ethics frameworks and policies and more for internal and external clients. She has a Master’s degree in bioethics from University of Toronto, Canada and Bachelor’s degree in Medical Biotechnology from Dr. D.Y. Patil Vidyapeeth, India. Lastly, her research interests include : exploring  the role of ethics in pharmaceutical industry, use of AI in healthcare and global health ethics.

Arianna Manzini (she/her) – Research Scientist, DeepMind.

Arianna is an ethicist and is very passionate about working in interdisciplinary teams to address complex societal challenges around technological advances. Arianna also has extensive experience in engaging the general publics in debates about technology and ethics, especially in health-related contexts. Before joining the Ethics Research Team at DeepMind, Arianna was Research Associate at the University of Bristol, where she collaborated with computer scientists and roboticists on a project on trustworthy autonomous systems. Arianna holds a PhD on ethical concerns around emerging technologies in autism genomics from the University of Oxford.

Leave a Reply

Your email address will not be published. Required fields are marked *